Search research articles
Contact Us
Filters
Showing results (91-100 of 116) with videos related to
Page
of 12
Sort By:
BMJ Open Ophthalmology
|
June 9, 2020
Complement factors and reticular pseudodrusen in intermediate age-related macular degeneration staged by multimodal imaging
Anne M Lynch, Alan G Palestine, Brandie D Wagner, et al.
American Journal of Ophthalmology
|
October 18, 2016
Cytomegalovirus Retinitis in Pediatric Stem Cell Transplants: Report of a Recent Cluster and the Development of a Screening Protocol
Marissa B Larochelle, Ryan Phan, John Craddock, et al.
European Journal of Ophthalmology
|
June 18, 2019
Systemic activation of the complement system in patients with advanced age-related macular degeneration
Anne M Lynch, Naresh Mandava, Jennifer L Patnaik, et al.
Journal of Translational Medicine
|
February 14, 2026
The immunological fitness of NSCLC patients drives the response to anti-PD1-based immunotherapy regardless of age
Lucrezia Tuosto, Alain Gelibter, Lidia Strigari, et al.
Drugs in Context
|
August 17, 2022
Advanced non-small-cell lung cancer: how to manage <i>EGFR</i> and <i>HER2</i> exon 20 insertion mutation-positive disease
Giulio Metro, Andrea De Giglio, Biagio Ricciuti, et al.
Cancers
|
March 28, 2025
Immunological Network Signature of Naïve Non-Oncogene-Addicted Non-Small Cell Lung Cancer Patients Treated with Anti-PD1 Therapy: A Pilot Study
Pasquale Sibilio, Ilaria Grazia Zizzari, Alain Gelibter, et al.
JTO Clinical and Research Reports
|
February 25, 2025
Clinical Utility of Combined Tissue and Plasma Next-Generation Sequencing in Patients With Advanced, Treatment-Naïve NSCLC
Helena Bote-de Cabo, Marco Siringo, Esther Conde, et al.
Translational Vision Science & Technology
|
January 31, 2019
Proteomic Profiles in Advanced Age-Related Macular Degeneration Using an Aptamer-Based Proteomic Technology
Anne M Lynch, Brandie D Wagner, Sophie J Weiss, et al.
Frontiers in Immunology
|
January 2, 2025
Anti-PD1 therapies induce an early expansion of Ki67<sup>+</sup>CD8<sup>+</sup> T cells in metastatic non-oncogene addicted NSCLC patients
Alain Gelibter, Lucrezia Tuosto, Angela Asquino, et al.
Journal of Translational Medicine
|
April 3, 2024
CD137<sup>+</sup> and regulatory T cells as independent prognostic factors of survival in advanced non-oncogene addicted NSCLC patients treated with immunotherapy as first-line
Alain Gelibter, Angela Asquino, Lidia Strigari, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 116) with videos related to
Sort By:
Page
of 12
BMJ Open Ophthalmology
|
June 9, 2020
Complement factors and reticular pseudodrusen in intermediate age-related macular degeneration staged by multimodal imaging
Anne M Lynch, Alan G Palestine, Brandie D Wagner, et al.
American Journal of Ophthalmology
|
October 18, 2016
Cytomegalovirus Retinitis in Pediatric Stem Cell Transplants: Report of a Recent Cluster and the Development of a Screening Protocol
Marissa B Larochelle, Ryan Phan, John Craddock, et al.
European Journal of Ophthalmology
|
June 18, 2019
Systemic activation of the complement system in patients with advanced age-related macular degeneration
Anne M Lynch, Naresh Mandava, Jennifer L Patnaik, et al.
Journal of Translational Medicine
|
February 14, 2026
The immunological fitness of NSCLC patients drives the response to anti-PD1-based immunotherapy regardless of age
Lucrezia Tuosto, Alain Gelibter, Lidia Strigari, et al.
Drugs in Context
|
August 17, 2022
Advanced non-small-cell lung cancer: how to manage <i>EGFR</i> and <i>HER2</i> exon 20 insertion mutation-positive disease
Giulio Metro, Andrea De Giglio, Biagio Ricciuti, et al.
Cancers
|
March 28, 2025
Immunological Network Signature of Naïve Non-Oncogene-Addicted Non-Small Cell Lung Cancer Patients Treated with Anti-PD1 Therapy: A Pilot Study
Pasquale Sibilio, Ilaria Grazia Zizzari, Alain Gelibter, et al.
JTO Clinical and Research Reports
|
February 25, 2025
Clinical Utility of Combined Tissue and Plasma Next-Generation Sequencing in Patients With Advanced, Treatment-Naïve NSCLC
Helena Bote-de Cabo, Marco Siringo, Esther Conde, et al.
Translational Vision Science & Technology
|
January 31, 2019
Proteomic Profiles in Advanced Age-Related Macular Degeneration Using an Aptamer-Based Proteomic Technology
Anne M Lynch, Brandie D Wagner, Sophie J Weiss, et al.
Frontiers in Immunology
|
January 2, 2025
Anti-PD1 therapies induce an early expansion of Ki67<sup>+</sup>CD8<sup>+</sup> T cells in metastatic non-oncogene addicted NSCLC patients
Alain Gelibter, Lucrezia Tuosto, Angela Asquino, et al.
Journal of Translational Medicine
|
April 3, 2024
CD137<sup>+</sup> and regulatory T cells as independent prognostic factors of survival in advanced non-oncogene addicted NSCLC patients treated with immunotherapy as first-line
Alain Gelibter, Angela Asquino, Lidia Strigari, et al.
Page
of 12